A recent study conducted by the Perelman School of Medicine at the University of Pennsylvania has shed light on how initial SARS-CoV-2 vaccinations can prepare immune cells to effectively respond to subsequent variants of the virus. The research, published in Immunity, focused on analyzing antibody responses in individuals who had been infected with or vaccinated against the BA.5 and XBB variants of SARS-CoV-2.
The study revealed that even though the BA.5 and XBB variants are markedly different from the original ancestral strain of SARS-CoV-2, the immune responses to these new variants predominantly stemmed from the existing B cell repertoire that had been established through prior vaccinations targeting the ancestral strain.
Notably, the antibody responses triggered by the initial vaccinations were found to be highly effective in preventing the BA.5 and XBB variants from infecting cells. This finding explains why booster shots based on these new variants were able to provide protection against severe illness. The study underscored the significance of the initial viral exposure in shaping immune responses to subsequent variants, even over an extended period.
Co-senior author of the study, Scott Hensley, Ph.D., highlighted the importance of understanding how the immune history of individuals influences their antibody responses to new variants. This knowledge, gained through studies like this one, will play a crucial role in developing more efficient vaccines in the future.
The researchers emphasized that the immune responses to the BA.5 and XBB variants were greatly influenced by the original B cell repertoire established by the ancestral SARS-CoV-2 strain. Individuals with a higher number of B cells developed in response to the ancestral strain were more likely to mount effective immune responses against the newer variants, primarily through cross-reactivity.
The study also investigated the concept of immunological imprinting, where the initial antibody response to a virus impacts the response to later strains of the same virus. The findings suggested that prior exposures to the ancestral SARS-CoV-2 strain significantly affected the antibody responses to the BA.5 and XBB variants, potentially influencing the robustness of protection against evolving variants in the future.
While the current responses to the variants appear to be protective, the researchers emphasized the need for ongoing monitoring of immune imprinting’s effects on SARS-CoV-2 responses through further studies. As the virus continues to evolve, understanding how prior exposures affect immunity to new variants and viral evolution will be crucial for developing effective strategies against emerging threats.
In conclusion, the study provided valuable insights into how initial SARS-CoV-2 vaccinations can prime the immune system to respond effectively to subsequent variants, highlighting the importance of continuous research to adapt to the evolving landscape of the pandemic.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
